查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1802997

2032 年微生物友善活性成分市場預測：按成分類型、形式、技術、分銷管道、應用、最終用戶和地區進行的全球分析

Microbiome-Friendly Actives Market Forecasts to 2032 - Global Analysis By Ingredient Type, Form, Technology, Distribution Channel, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

據 Stratistics MRC 稱，全球微生物組友善活性成分市場預計在 2025 年達到 3.116 億美元，到 2032 年將達到 15.973 億美元，預測期內的複合年成長率為 26.3%。微生物組友善活性成分是專門配製的生物活性成分，用於支持、保護和平衡人體皮膚和腸道細菌——維持健康的有益微生物的複雜生態系統。這些活性成分透過促進有益細菌的生長、抑制有害微生物和維持天然微生物多樣性來發揮作用，這對屏障功能、免疫力和整體健康至關重要。與可能破壞微生物平衡的傳統化學物質不同，微生物組友善活性成分溫和且具針對性，通常來自益生元、益生菌和後生元。它們的應用涵蓋護膚、個人護理和營養，反映出消費者對安全有效地培育天然微生物健康的產品的需求日益成長。

個人化護膚需求日益成長

個人化護膚需求的日益成長，對微生物友善活性成分市場產生了強烈而積極的影響。消費者越來越尋求符合自身獨特皮膚微生物組的客製化解決方案，這推動了創新和產品多樣化。這一趨勢促使護膚品牌開發針對特定需求（例如敏感性肌膚、痤瘡和老齡化，同時保持微生物組的平衡。隨著人們對微生物組健康的認知不斷提高，個人化方法正在提升消費者的信任度和滿意度，從而刺激市場採用，並加速整個產業的成長機會。

研發和配方成本高

由於研發和配方成本高昂，微生物友善活性成分市場面臨巨大限制，阻礙了快速創新和產品開發。高成本增加了中小企業的進入門檻，並限制了它們有效擴展解決方案的能力。因此，市場擴張可能會放緩，價格可能維持高位，消費者和製造商的採用可能會受到抑制，最終阻礙該行業的整體成長軌跡。

清潔美容與益生菌/益生元趨勢

清潔美容和益生菌/益生元趨勢的日益流行正在積極推動市場發展。清潔美容強調透明度、永續性，並避免使用刺激性化學物質，而益生菌和益生元的創新則有助於維持皮膚微生物群的平衡，從而提升產品的可信度和需求。這種協同效應鼓勵品牌將有益於微生物群的活性成分融入護膚方案中，從而推動創新、消費者信任和採用，最終推動市場持續擴張。

監管模糊性

由於監管不明確，微生物組友善活性成分市場面臨負面影響和阻礙因素，這導致產品核可、安全標準和標籤要求等方面的不確定性。企業難以協調不同地區不一致的指導方針，導致產品發布延遲並增加合規成本。這種不確定性可能會抑制研發和創新投資，減緩市場擴張，限制消費者接受度，並最終限制以微生物組為重點的醫療保健和個人護理行業的整體成長潛力。

COVID-19的影響

新冠疫情以多種方式影響了微生物友善活性成分市場。最初，供應鏈中斷、生產放緩以及消費者支出減少阻礙了成長。然而，這場危機提高了人們對免疫健康、腸道健康和個人健康的認知，推動了對基於微生物組的護膚和營養產品的長期需求。消費者越來越尋求天然、安全且有科學依據的解決方案，儘管疫情期間存在短期挑戰，但微生物友善活性成分仍被視為一個具有韌性且前景廣闊的類別。

預測期內，合益素市場預計將成為最大的市場

預計合益素領域將在預測期內佔據最大的市場佔有率，這得益於益生元和益生菌的靶向融合，形成協同配方，從而增強腸道-皮膚和腸道-腦軸的功能。這種融合，加上消費者對整體和生物活性解決方案日益成長的需求，正在推動功能性護膚、可食用產品和健康產品的創新。合益素還能實現精準的微生物組調控，增強監管信心並獲得科學檢驗。因此，合益素正在重塑產品開發平臺，並加速其在美容、營養保健品和治療領域的應用。

預計血清部分在預測期內將出現最高的複合年成長率。

預計精華液細分市場將在預測期內達到最高成長率。受消費者對簡約高效配方日益成長的需求推動，精華液為整合後生元和發酵萃取物等微生物平衡成分提供了一種理想的形式。其輕盈的質地和精準的靶向性提高了成分的生物生物有效性，促進了活性成分封裝和協同增效配方的創新。這種融合正在推動優質化，拓展藥妝應用，並將微生物友善活性成分定位為下一代皮膚健康的重要支柱。

佔比最大的地區：

在預測期內，亞太地區預計將佔據最大的市場佔有率，這得益於消費者對整體健康和科學配方日益成長的需求。人們對腸道-皮膚-大腦之間連結的認知日益加深，促使各大品牌在食品、個人護理和補充劑領域不斷創新，以促進微生物平衡。受人口老化和積極主動的健康策略推動，日本和東南亞在微生物組友善活性成分的應用方面處於領先地位。該地區的監管變化和研發投入進一步推動了成長，將微生物友善活性成分定位為預防性醫療保健和消費者信任的變革力量。

複合年成長率最高的地區：

預計北美將在預測期內實現最高的複合年成長率，這得益於消費者對腸道和皮膚健康的日益關注、對天然和潔淨標示產品的需求以及個性化護膚行業的興起。該地區先進的研發生態系統、領先的化妝品和營養保健品牌的湧現，以及強化的安全性和功效監管，將進一步加速市場應用。生物技術創新投資的不斷增加以及消費者對益生菌和益生元活性成分的偏好，正在推動其穩定成長。

免費客製化服務：

此報告的訂閱者可以從以下免費自訂選項中選擇一項：

  • 公司簡介
    • 全面分析其他市場參與者（最多 3 家公司）
    • 主要企業的SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家進行的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 主要研究資料
    • 次級研究資訊來源
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 抑制因素
  • 機會
  • 威脅
  • 技術分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球微生物友善活性成分市場（依成分類型）

  • 益生元
  • 益生菌
  • 後生元
  • 合益素
  • 植物萃取物
  • 胜肽
  • 維生素和礦物質

6. 全球微生物友善活性成分市場（依形式）

  • 膠囊和片劑
  • 粉末
  • 液體
  • 軟糖
  • 乳霜和乳液
  • 美容精華液
  • 油

7. 全球微生物友善活性成分市場（按技術）

  • 基於基因體學的活性成分
  • 代謝體學衍生化合物
  • 人工智慧驅動的個人化微生物組處方
  • 封裝和遞送系統

8. 全球微生物友善活性成分市場（依通路）

  • 大賣場/超級市場
  • 專賣店
  • 藥局
  • 網路零售
  • 皮膚科診所

9. 全球微生物友善活性成分市場（按應用）

  • 護膚
  • 護髮
  • 口腔清潔用品
  • 女性衛生
  • 嬰兒護理
  • 傷口癒合
  • 抗衰老和屏障修復

第 10 章。全球微生物組友善活性成分市場（按最終用戶）

  • 成人
  • 孩子
  • 老年人
  • 寵物和牲畜

11. 全球微生物友善活性成分市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第12章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第13章：企業概況

  • Chr. Hansen Holding A/S
  • DuPont
  • Lonza Group AG
  • Yakult Honsha Co., Ltd.
  • Lesaffre Group
  • Nestle Health Science
  • Danone SA
  • Evonik Industries AG
  • BioGaia AB
  • DSM-Firmenich AG
  • Probi AB
  • SynbioTech Inc.
  • Kerry Group plc
  • Novozymes A/S
  • Herbalife Nutrition Ltd.
  • Arla Foods Ingredients Group
  • Sabinsa Corporation
  • Morinaga Milk Industry Co., Ltd.
Product Code: SMRC30523

According to Stratistics MRC, the Global Microbiome-Friendly Actives Market is accounted for $311.6 million in 2025 and is expected to reach $1,597.3 million by 2032 growing at a CAGR of 26.3% during the forecast period. Microbiome-Friendly Actives are bioactive ingredients specifically formulated to support, protect, and balance the human skin or gut microbiome-the complex ecosystem of beneficial microorganisms that maintain health. These actives work by promoting the growth of beneficial bacteria, inhibiting harmful microbes, and preserving the natural microbial diversity essential for barrier function, immunity, and overall wellbeing. Unlike traditional chemicals that may disrupt microbial balance, microbiome-friendly actives are gentle, targeted, and often derived from prebiotics, probiotics, or postbiotics. Their application spans skincare, personal care, and nutrition, reflecting a growing consumer demand for products that nurture natural microbial health safely and effectively.

Market Dynamics:

Driver:

Rising demand for personalized skincare

The rising demand for personalized skincare is creating a strong and positive impact on the Microbiome-Friendly Actives Market. Consumers are increasingly seeking tailored solutions that align with their unique skin microbiome, driving innovation and product diversification. This trend encourages skincare brands to develop formulations that target specific needs such as sensitivity, acne, or aging, while preserving microbiome balance. As awareness about microbiome health grows, personalized approaches enhance customer trust and satisfaction, fueling market adoption and accelerating growth opportunities across the sector.

Restraint:

High R&D and formulation costs

The Microbiome-Friendly Actives Market faces a notable constraint due to high R&D and formulation costs, which hinder rapid innovation and product development. These elevated expenses increase entry barriers for smaller companies and limit the ability to scale solutions efficiently. As a result, market expansion is slowed, pricing remains elevated, and adoption by consumers and manufacturers may be restrained, ultimately impeding the sector's overall growth trajectory.

Opportunity:

Clean beauty and probiotic/prebiotic trends

The growing popularity of clean beauty and probiotic/prebiotic trends is positively driving the market, as consumers increasingly seek products that promote skin health through natural, safe, and effective formulations. Clean beauty emphasizes transparency, sustainability, and avoidance of harsh chemicals, while probiotic and prebiotic innovations support balanced skin microbiota, boosting product credibility and demand. This synergy encourages brands to integrate microbiome-friendly actives into skincare solutions, fostering innovation, consumer trust, and widespread adoption, ultimately fueling sustained market expansion.

Threat:

Regulatory ambiguity

The Microbiome-Friendly Actives Market faces a negative and hindering impact due to regulatory ambiguity, which creates uncertainty around product approvals, safety standards, and labeling requirements. Companies struggle to navigate inconsistent guidelines across regions, delaying product launches and increasing compliance costs. This uncertainty discourages investment in research and innovation, slows market expansion, and may result in limited consumer adoption, ultimately constraining the overall growth potential of the microbiome-focused health and personal care sector.

Covid-19 Impact

The Covid-19 pandemic had a mixed impact on the Microbiome-Friendly Actives Market. Initially, disruptions in supply chains, manufacturing slowdowns, and reduced consumer spending hindered growth. However, the crisis heightened awareness of immune health, gut health, and personal wellness, driving long-term demand for microbiome-based skincare and nutritional products. Consumers increasingly sought natural, safe, and science-backed solutions, positioning microbiome-friendly actives as a resilient and promising category despite short-term challenges during the pandemic.

The synbiotics segment is expected to be the largest during the forecast period

The synbiotics segment is expected to account for the largest market share during the forecast period, because of merging targeted prebiotics and probiotics into synergistic formulations that enhance gut-skin and gut-brain axes. This convergence is driving innovation in functional skincare, ingestibles, and wellness products, with rising consumer demand for holistic, bioactive solutions. Synbiotics also enable precision microbiome modulation, fostering regulatory confidence and scientific validation. As a result, they're reshaping product development pipelines and accelerating adoption across beauty, nutraceutical, and therapeutic verticals.

The serums segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the serums segment is predicted to witness the highest growth rate, due to rising consumer demand for minimalist, high-efficacy formulations, serums offer an ideal format for incorporating microbiome-balancing ingredients like postbiotics and fermented extracts. Their lightweight, targeted nature enhances ingredient bioavailability, driving innovation in active encapsulation and synergistic blends. This convergence is fostering premiumization, expanding dermocosmetic applications, and positioning microbiome-friendly actives as essential pillars of next-gen skin health.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share due to rising consumer demand for holistic wellness and scientifically backed formulations. With growing awareness of gut-skin-brain connections, brands are innovating across food, personal care, and supplements to support microbial balance. Japan and Southeast Asia lead adoption, fueled by aging populations and proactive health strategies. Regulatory shifts and regional R&D investments further accelerate growth, positioning microbiome-friendly actives as a transformative force in preventive healthcare and consumer trust.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to rising consumer awareness of gut-skin health connection, demand for natural and clean-label products, and a thriving personalized skincare industry. The region's advanced R&D ecosystem, presence of leading cosmetic and nutraceutical brands, and strong regulatory emphasis on safety and efficacy further accelerate market adoption. Growing investments in biotech innovations and consumer preference for probiotic and prebiotic-based actives reinforce steady growth momentum.

Key players in the market

Some of the key players profiled in the Microbiome-Friendly Actives Market include Chr. Hansen Holding A/S, DuPont, Lonza Group AG, Yakult Honsha Co., Ltd., Lesaffre Group, Nestle Health Science, Danone S.A., Evonik Industries AG, BioGaia AB, DSM-Firmenich AG, Probi AB, SynbioTech Inc., Kerry Group plc, Novozymes A/S, Herbalife Nutrition Ltd., Arla Foods Ingredients Group, Sabinsa Corporation and Morinaga Milk Industry Co., Ltd.

Key Developments:

In June 2025, Nestle has embarked on collaborations in New Zealand and the UK to explore integrated multi-trophic aquaculture, where seaweed and shellfish mutually nourish one another. This approach promises a graceful, sustainable symbiosis-boosting biodiversity, water quality, and ecosystem restoration.

In May 2025, DuPont and Epicore Biosystems have partnered to fuse DuPont's protective garment expertise with Epicore's sweat-sensing Connected Hydration wearables, aiming to deliver real-time biometrics and personalized hydration insights to enhance worker safety in heat-stress environments.

In June 2025, Ethris has partnered with Lonza to develop room-temperature-stable, spray-dried mRNA vaccine formulations for mucosal delivery via nasal administration, beginning with an influenza candidate. This method promises to simplify cold-chain logistics and enhance accessibility for respiratory disease prevention.

Ingredient Types Covered:

  • Prebiotics
  • Probiotics
  • Postbiotics
  • Synbiotics
  • Botanical Extracts
  • Peptides
  • Vitamins & Minerals

Forms Covered:

  • Capsules & Tablets
  • Powders
  • Liquids
  • Gummies
  • Creams & Lotions
  • Serums
  • Oils

Technologies Covered:

  • Genomics-based Actives
  • Metabolomics-derived Compounds
  • AI-personalized Microbiome Formulations
  • Encapsulation & Delivery Systems

Distribution Channels Covered:

  • Hypermarkets/Supermarkets
  • Specialty Stores
  • Pharmacies
  • Online Retail
  • Dermatology Clinics

Applications Covered:

  • Skin Care
  • Hair Care
  • Oral Care
  • Feminine Hygiene
  • Baby Care
  • Wound Healing
  • Anti-aging & Barrier Repair

End Users Covered:

  • Adults
  • Children
  • Geriatric Population
  • Pets & Livestock

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Microbiome-Friendly Actives Market, By Ingredient Type

  • 5.1 Introduction
  • 5.2 Prebiotics
  • 5.3 Probiotics
  • 5.4 Postbiotics
  • 5.5 Synbiotics
  • 5.6 Botanical Extracts
  • 5.7 Peptides
  • 5.8 Vitamins & Minerals

6 Global Microbiome-Friendly Actives Market, By Form

  • 6.1 Introduction
  • 6.2 Capsules & Tablets
  • 6.3 Powders
  • 6.4 Liquids
  • 6.5 Gummies
  • 6.6 Creams & Lotions
  • 6.7 Serums
  • 6.8 Oils

7 Global Microbiome-Friendly Actives Market, By Technology

  • 7.1 Introduction
  • 7.2 Genomics-based Actives
  • 7.3 Metabolomics-derived Compounds
  • 7.4 AI-personalized Microbiome Formulations
  • 7.5 Encapsulation & Delivery Systems

8 Global Microbiome-Friendly Actives Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Hypermarkets/Supermarkets
  • 8.3 Specialty Stores
  • 8.4 Pharmacies
  • 8.5 Online Retail
  • 8.6 Dermatology Clinics

9 Global Microbiome-Friendly Actives Market, By Application

  • 9.1 Introduction
  • 9.2 Skin Care
  • 9.3 Hair Care
  • 9.4 Oral Care
  • 9.5 Feminine Hygiene
  • 9.6 Baby Care
  • 9.7 Wound Healing
  • 9.8 Anti-aging & Barrier Repair

10 Global Microbiome-Friendly Actives Market, By End User

  • 10.1 Introduction
  • 10.2 Adults
  • 10.3 Children
  • 10.4 Geriatric Population
  • 10.5 Pets & Livestock

11 Global Microbiome-Friendly Actives Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Chr. Hansen Holding A/S
  • 13.2 DuPont
  • 13.3 Lonza Group AG
  • 13.4 Yakult Honsha Co., Ltd.
  • 13.5 Lesaffre Group
  • 13.6 Nestle Health Science
  • 13.7 Danone S.A.
  • 13.8 Evonik Industries AG
  • 13.9 BioGaia AB
  • 13.10 DSM-Firmenich AG
  • 13.11 Probi AB
  • 13.12 SynbioTech Inc.
  • 13.13 Kerry Group plc
  • 13.14 Novozymes A/S
  • 13.15 Herbalife Nutrition Ltd.
  • 13.16 Arla Foods Ingredients Group
  • 13.17 Sabinsa Corporation
  • 13.18 Morinaga Milk Industry Co., Ltd.

List of Tables

  • Table 1 Global Microbiome-Friendly Actives Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Microbiome-Friendly Actives Market Outlook, By Ingredient Type (2024-2032) ($MN)
  • Table 3 Global Microbiome-Friendly Actives Market Outlook, By Prebiotics (2024-2032) ($MN)
  • Table 4 Global Microbiome-Friendly Actives Market Outlook, By Probiotics (2024-2032) ($MN)
  • Table 5 Global Microbiome-Friendly Actives Market Outlook, By Postbiotics (2024-2032) ($MN)
  • Table 6 Global Microbiome-Friendly Actives Market Outlook, By Synbiotics (2024-2032) ($MN)
  • Table 7 Global Microbiome-Friendly Actives Market Outlook, By Botanical Extracts (2024-2032) ($MN)
  • Table 8 Global Microbiome-Friendly Actives Market Outlook, By Peptides (2024-2032) ($MN)
  • Table 9 Global Microbiome-Friendly Actives Market Outlook, By Vitamins & Minerals (2024-2032) ($MN)
  • Table 10 Global Microbiome-Friendly Actives Market Outlook, By Form (2024-2032) ($MN)
  • Table 11 Global Microbiome-Friendly Actives Market Outlook, By Capsules & Tablets (2024-2032) ($MN)
  • Table 12 Global Microbiome-Friendly Actives Market Outlook, By Powders (2024-2032) ($MN)
  • Table 13 Global Microbiome-Friendly Actives Market Outlook, By Liquids (2024-2032) ($MN)
  • Table 14 Global Microbiome-Friendly Actives Market Outlook, By Gummies (2024-2032) ($MN)
  • Table 15 Global Microbiome-Friendly Actives Market Outlook, By Creams & Lotions (2024-2032) ($MN)
  • Table 16 Global Microbiome-Friendly Actives Market Outlook, By Serums (2024-2032) ($MN)
  • Table 17 Global Microbiome-Friendly Actives Market Outlook, By Oils (2024-2032) ($MN)
  • Table 18 Global Microbiome-Friendly Actives Market Outlook, By Technology (2024-2032) ($MN)
  • Table 19 Global Microbiome-Friendly Actives Market Outlook, By Genomics-based Actives (2024-2032) ($MN)
  • Table 20 Global Microbiome-Friendly Actives Market Outlook, By Metabolomics-derived Compounds (2024-2032) ($MN)
  • Table 21 Global Microbiome-Friendly Actives Market Outlook, By AI-personalized Microbiome Formulations (2024-2032) ($MN)
  • Table 22 Global Microbiome-Friendly Actives Market Outlook, By Encapsulation & Delivery Systems (2024-2032) ($MN)
  • Table 23 Global Microbiome-Friendly Actives Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 24 Global Microbiome-Friendly Actives Market Outlook, By Hypermarkets/Supermarkets (2024-2032) ($MN)
  • Table 25 Global Microbiome-Friendly Actives Market Outlook, By Specialty Stores (2024-2032) ($MN)
  • Table 26 Global Microbiome-Friendly Actives Market Outlook, By Pharmacies (2024-2032) ($MN)
  • Table 27 Global Microbiome-Friendly Actives Market Outlook, By Online Retail (2024-2032) ($MN)
  • Table 28 Global Microbiome-Friendly Actives Market Outlook, By Dermatology Clinics (2024-2032) ($MN)
  • Table 29 Global Microbiome-Friendly Actives Market Outlook, By Application (2024-2032) ($MN)
  • Table 30 Global Microbiome-Friendly Actives Market Outlook, By Skin Care (2024-2032) ($MN)
  • Table 31 Global Microbiome-Friendly Actives Market Outlook, By Hair Care (2024-2032) ($MN)
  • Table 32 Global Microbiome-Friendly Actives Market Outlook, By Oral Care (2024-2032) ($MN)
  • Table 33 Global Microbiome-Friendly Actives Market Outlook, By Feminine Hygiene (2024-2032) ($MN)
  • Table 34 Global Microbiome-Friendly Actives Market Outlook, By Baby Care (2024-2032) ($MN)
  • Table 35 Global Microbiome-Friendly Actives Market Outlook, By Wound Healing (2024-2032) ($MN)
  • Table 36 Global Microbiome-Friendly Actives Market Outlook, By Anti-aging & Barrier Repair (2024-2032) ($MN)
  • Table 37 Global Microbiome-Friendly Actives Market Outlook, By End User (2024-2032) ($MN)
  • Table 38 Global Microbiome-Friendly Actives Market Outlook, By Adults (2024-2032) ($MN)
  • Table 39 Global Microbiome-Friendly Actives Market Outlook, By Children (2024-2032) ($MN)
  • Table 40 Global Microbiome-Friendly Actives Market Outlook, By Geriatric Population (2024-2032) ($MN)
  • Table 41 Global Microbiome-Friendly Actives Market Outlook, By Pets & Livestock (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.